op200326s_si_001.pdf (1.11 MB)
Download filePractical and Scalable Synthesis of S1P1 Receptor Agonist ACT-209905
journal contribution
posted on 20.04.2012, 00:00 authored by Gunther Schmidt, Stefan Reber, Martin H. Bolli, Stefan AbeleA practical and scalable route for the fast delivery
of 12 kg of
S1P1 agonist (ACT-209905) has been developed. ACT-209905
is composed of an amino pyridine group, an oxadiazole spacer, a 2-ethyl-5-methylphenol
moiety and a chiral 1-amino-2-propanol side chain. The convergent
synthesis consists of 16 steps with 9 isolated intermediates and is
chromatography-free. Key building blocks are accessed from low-cost
starting materials, such as acetone, diethyl oxalate, cyanoacetamide,
and 2-ethyl-5-methyl aniline. A Negishi coupling that was troubled
by the use of metal reagents and concomitant metal waste streams has
been replaced by a less expensive Guareschi–Thorpe reaction
to build up an amino isonicotinic acid. The chiral 1-amino-2-propanol
moiety was secured by selective ring-opening of an epoxide with lithium
hexamethyldisilazide as an ammonia surrogate, thus omitting the notorious
double alkylated byproduct.
History
Usage metrics
Read the peer-reviewed publication
Categories
Keywords
Key building blocksammoniametal waste streams12 kgmaterialNegishiacetoneGuareschilithium hexamethyldisilazidediethyl oxalateAgonistchiralpyridine group16 stepsmoietymetal reagentsisonicotinic acidintermediateS 1P agonistReceptoranilineepoxidealkylated byproductScalable SynthesiscyanoacetamidePracticaloxadiazole spacerscalable routeconvergent synthesis